Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing-Commentary. Gratch D, Zhovtis Ryerson L. Mult Scler 2022;28:695-696.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gratch D, Zhovtis Ryerson L. Stable multiple sclerosis patients on anti-CD20 therapy should go on extended interval dosing-Commentary. Mult Scler 2022;28:695-696.
PMID: 35365058